Olive Leaf Extracts in the Control of Diabet

Last updated: June 1, 2025
Sponsor: University of Monastir
Overall Status: Active - Recruiting

Phase

2/3

Condition

Diabetes Mellitus, Type 2

Treatment

Placebo Atherolive

Atherolive

Clinical Study ID

NCT05605704
Diab-Atherolive
  • Ages 18-100
  • All Genders

Study Summary

This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital).

Patients over 18 years of age with:

-Diabets

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients over 18 years of age with:

  • diabetes.

Exclusion

Exclusion Criteria:

  • Exclusion criteria: None.

Study Design

Total Participants: 500
Treatment Group(s): 2
Primary Treatment: Placebo Atherolive
Phase: 2/3
Study Start date:
January 01, 2023
Estimated Completion Date:
December 15, 2025

Study Description

This study will be carried out in 2 emergency departments (at the exit of the emergency room, patients included in the GR2 study) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital).

All the population will benifit of a biological assessment which include:

  • Complete lipid profile, blood sugar, creatinine

  • HbA1c (if the patient is diabetic).

  • Inflammatory assessment: reactive protein C One population will be rendomized:The population with diabetes. In each study population, the patient will be assigned to one of two treatments (atherolive or placebo). The study drug (atherol) will be prescribed at a dose of 400 mg, once a day for 3 months. The placebo will be prescribed identically.

Continuous blood glucose monitoring to measure indices of glycemic variability is performed at baseline. These patients will be equipped with an iPro continuous glycemic monitoring

Connect with a study center

  • Semir Nouira

    Monastir, Monastir Tunisia 5000
    Tunisia

    Active - Recruiting

+−

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.